# Randomised EValuation of Therapies for microvAscuLar Injury in STEACS

> **NCT06935383** · PHASE2 · NOT_YET_RECRUITING · sponsor: **CorFlow Therapeutics AG** · enrollment: 250 (estimated)

## Conditions studied

- STEMI (ST Elevation MI)

## Interventions

- **DEVICE:** Therapeutic sequence
- **DEVICE:** Diagnostic sequence

## Key facts

- **NCT ID:** NCT06935383
- **Lead sponsor:** CorFlow Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06935383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06935383, "Randomised EValuation of Therapies for microvAscuLar Injury in STEACS". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06935383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*